Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q3 2021 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2021-11-12

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 12, 2021

Total Value: $679M (100.0% shares, 0.0% debt)

Holdings (12)

— Kinnate Biopharma Inc. 32.8%

Value $223M Shares 9,671,643 Est. Cost $39.78 Unrealized —

— Lyell Immunopharma, Inc. 28.9%

Value $197M Shares 13,282,181 Est. Cost $16.24 Unrealized —

ACRS Aclaris Therapeutics, Inc. 9.0%

Value $61.18M Shares 3,399,034 Est. Cost $15.18 Unrealized +5.6%

PHVS Pharvaris N.V. 8.5%

Value $57.83M Shares 3,261,926 Est. Cost $31.46 Unrealized -45.6%

QSI Quantum-Si Incorporated 5.5%

Value $37.23M Shares 4,463,619 Est. Cost $10.48 Unrealized -6.0%

NRIX Nurix Therapeutics, Inc. 5.3%

Value $36.13M Shares 1,205,798 Est. Cost $25.20 Unrealized +22.5%

KURA Kura Oncology, Inc. 5.1%

Value $34.65M Shares 1,849,947 Est. Cost $20.39 Unrealized -7.6%

HLTHQ Cue Health Inc. 1.7%

Value $11.88M Shares 1,006,089 Est. Cost $11.81 Unrealized —

OLMA Olema Pharmaceuticals, Inc. 1.4%

Value $9.426M Shares 342,030 Est. Cost $46.89 Unrealized -42.4%

— Cymabay Therapeutics, Inc. 1.0%

Value $6.523M Shares 1,787,094 Est. Cost $3.49 Unrealized —

— Tempest Therapeutics, Inc. 0.4%

Value $2.752M Shares 190,213 Est. Cost $11.18 Unrealized —

— Decibel Therapeutics, Inc. 0.3%

Value $2.295M Shares 297,711 Est. Cost $11.36 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Kinnate Biopharma Inc.	9,671,643	$223M	32.8%	$39.78	—	COM	49705R105
—	Lyell Immunopharma, Inc.	13,282,181	$197M	28.9%	$16.24	—	COM	55083R104
ACRS	Aclaris Therapeutics, Inc.	3,399,034	$61.18M	9.0%	$15.18	+5.6%	COM	00461U105
PHVS	Pharvaris N.V.	3,261,926	$57.83M	8.5%	$31.46	-45.6%	COM	N69605108
QSI	Quantum-Si Incorporated	4,463,619	$37.23M	5.5%	$10.48	-6.0%	COM CL A	74765K105
NRIX	Nurix Therapeutics, Inc.	1,205,798	$36.13M	5.3%	$25.20	+22.5%	COM	67080M103
KURA	Kura Oncology, Inc.	1,849,947	$34.65M	5.1%	$20.39	-7.6%	COM	50127T109
HLTHQ	Cue Health Inc.	1,006,089	$11.88M	1.7%	$11.81	—	COM	229790100
OLMA	Olema Pharmaceuticals, Inc.	342,030	$9.426M	1.4%	$46.89	-42.4%	COM	68062P106
—	Cymabay Therapeutics, Inc.	1,787,094	$6.523M	1.0%	$3.49	—	COM	23257D103
—	Tempest Therapeutics, Inc.	190,213	$2.752M	0.4%	$11.18	—	COM	87978U108
—	Decibel Therapeutics, Inc.	297,711	$2.295M	0.3%	$11.36	—	COM	24343R106